GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Research & Development

Statera BioPharma (STU:7CB) Research & Development : €9.01 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Statera BioPharma's Research & Development for the three months ended in Sep. 2022 was €0.23 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was €9.01 Mil.


Statera BioPharma Research & Development Historical Data

The historical data trend for Statera BioPharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Research & Development Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Research & Development
0.53 4.33 10.47

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.92 4.92 2.94 0.92 0.23

Statera BioPharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma  (STU:7CB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Statera BioPharma Research & Development Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines